| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.04. | Adia Nutrition Inc.: Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study | 249 | Newsfile | Winter Park, Florida--(Newsfile Corp. - April 8, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, today announced a strategic partnership with a prominent clinic in... ► Artikel lesen | |
| 02.04. | Adia Nutrition, Inc. GAAP EPS of $0.00 | 1 | Seeking Alpha | ||
| 01.04. | Adia Nutrition Inc.: Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status | 308 | Newsfile | Winter Park, Florida--(Newsfile Corp. - April 1, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions, today announced... ► Artikel lesen | |
| ADIA NUTRITION Aktie jetzt für 0€ handeln | |||||
| 31.03. | Adia Nutrition, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 24.03. | Adia Nutrition Inc.: Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building | 171 | Newsfile | Winter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med division, is excited to announce a special virtual... ► Artikel lesen | |
| 17.03. | Adia Nutrition Inc.: Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division | 456 | Newsfile | Winter Park, Florida--(Newsfile Corp. - March 17, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its subsidiary, Adia Med of Winter Park, has appointed Amy Dalrymple, MSN, APRN... ► Artikel lesen | |
| 09.03. | Adia Nutrition Inc.: Adia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies | 484 | Newsfile | Orlando, Florida--(Newsfile Corp. - March 9, 2026) - Adia Nutrition's (OTCQB: ADIA) subsidiary, Adia Med, has launched a complete digital refresh of its online presence. Through a strategic partnership... ► Artikel lesen | |
| 03.03. | Adia Nutrition Inc.: Adia Nutrition Announces Submission of Final Revised Protocol for Lower Back Pain Study with AdiaVita | 384 | Newsfile | Winter Park, Florida--(Newsfile Corp. - March 3, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a company focused on regenerative medicine and therapeutic solutions, today announced that its subsidiary... ► Artikel lesen | |
| 24.02. | Adia Nutrition Inc.: Adia Med of Winter Park Expands into Cosmetics Due to High Patient Demand - Now Interviewing Nurse Practitioners for Hair Growth and Aesthetic Procedures | 154 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative wellness solutions through its subsidiary Adia Med... ► Artikel lesen | |
| 16.02. | Adia Nutrition Inc.: Adia Nutrition Announces Subsidiary Adia Med's Submission of Second Clinical Study for IRB Review Targeting Lower Back Pain with AdiaVita | 332 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 16, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative therapeutic solutions, today announced that its subsidiary... ► Artikel lesen | |
| 09.02. | Adia Nutrition Inc.: Adia Nutrition Inc. Plans to Initiate Four to Five New Clinical Studies in 2026, Including Expansions in Autism and New Rheumatoid Arthritis Research | 322 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 9, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its subsidiary Adia Med, today announced an ambitious expansion... ► Artikel lesen | |
| 04.02. | Adia Nutrition Inc.: Adia Nutrition Inc. Announces Effectiveness of Form 10 Registration Statement - Now a Fully Reporting SEC Company and Advancing Toward Next Phase of Growth and NASDAQ Uplisting | 323 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 4, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions through its... ► Artikel lesen | |
| 02.02. | Adia Nutrition Inc.: Adia Nutrition Inc. Announces Dr. Brian Browning as Lead Physician for All Orthopedic Treatments and Specialties at Adia Med | 286 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 2, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions through its... ► Artikel lesen | |
| 28.01. | Adia Nutrition Inc.: Adia Nutrition Announces Documentary Featuring WWE/TNA Superstar Elias/Elijah Jeff Sciullo's Recovery with Adia Med's AdiaVita Stem Cell Treatment | 563 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 28, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in regenerative therapies, is proud to announce... ► Artikel lesen | |
| 26.01. | Adia Nutrition Inc.: Adia Nutrition Announces Every Child in Autism Stem Cell Study Receives Umbilical Cord Blood-Derived Stem Cell Treatments Three Times - Open Nationwide and Worldwide with Participation Cost | 346 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its subsidiary Adia Med of Winter Park, LLC, today highlighted key details of its ongoing IRB-approved... ► Artikel lesen | |
| 20.01. | Adia Nutrition Inc.: Adia Nutrition Inc. Receives Notification from SEC: Form 10 to Become Effective on February 3, 2026 | 337 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and personalized healthcare, today announced that it has been notified... ► Artikel lesen | |
| 15.01. | Adia Nutrition Inc.: Adia Nutrition Promotes Emmanuela Derisbrun, APRN, FNP-C, to Provider Role Amid Growing Patient Demand and Launch of Autism IRB Study | 350 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in advanced regenerative therapies, announces that... ► Artikel lesen | |
| 13.01. | Adia Nutrition Inc.: Adia Med Kicks Off Recruitment Today for Innovative Autism Stem Cell Study | 366 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun the recruitment... ► Artikel lesen | |
| 08.01. | ADIA Nutrition appoints Dawn Bell as chief revenue officer | 1 | Investing.com | ||
| 08.01. | Adia Nutrition Inc.: ADIA Nutrition Appoints Dawn Bell as Chief Revenue Officer to Accelerate Growth and Drive Success Across Physician Network | 271 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 8, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a rapidly growing leader in regenerative medicine, today announced the appointment of Dawn Bell as... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,850 | +0,81 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,650 | -0,92 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,290 | +1,32 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,280 | +1,48 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| PROGYNY | 17,170 | +1,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 24,590 | +4,82 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| ADAPTHEALTH | 12,770 | +3,74 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| CARL ZEISS MEDITEC | 27,100 | +3,20 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Carl Zeiss Meditec von 36 auf 31 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Die Aktien der Jenaer... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,700 | +5,23 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106 Augenapplikatoren | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106... ► Artikel lesen | |
| GERRESHEIMER | 17,400 | +1,87 % | Gerresheimer fliegt aus dem SDax | Der Bilanzstreit kostet dem Verpackungskonzern Gerresheimer den Indexplatz im SDAX, während die Shelly Group als Nachrücker in den Kleinwerteindex aufsteigt. Der angeschlagene Verpackungshersteller... ► Artikel lesen | |
| DRAEGERWERK | 97,00 | +1,89 % | Draegerwerk AG & Co. KGaA: Online-Präsentation für Investoren als Teil der German Select 7 Conference am 14.04.2026 | Vor diesem Hintergrund veranstaltet mwb research am 14.04.2026 um 14:00 CEST einen Online-Roundtable mit Thomas Fischler (Head of Treasury & Investor Relations). Nach einer Präsentation besteht die... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 46,040 | -0,04 % | BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026 | ||
| MIMEDX | 3,920 | +0,26 % | MiMedx Group, Inc: MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX Thyroid Shields | MARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced the commercial launch of AMNIOFIX Thyroid Shields, a product line extension... ► Artikel lesen | |
| BILLIONTOONE | 82,57 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| UNITEDHEALTH | 267,60 | +0,53 % | UnitedHealth-Aktie: Auftakt zu einem großen Comeback? | Seit über zwei Monaten dümpelt die UnitedHealth-Aktie in einem Seitwärtstrend vor sich hin. Doch am Dienstagmorgen gelingt der größten Krankenversicherung der USA mit einem Kursplus von über +8% der... ► Artikel lesen |